Naturhouse Health SA
No trades
No trades
0.17 EUR
10.09 M EUR
47.63 M EUR
12.98 M
Company info
Sector
Industry
CEO
Félix Revuelta Fernández
Website
Headquarters
Madrid
Founded
1986
IPO date
Apr 9, 2015
ISIN
ES0105043006
FIGI
BBG00JHW6VM0
Identifiers
ISIN ES0105043006
Naturhouse Health SA engages in the exportation, wholesale and retail sale of products related to dietetics, medicinal herbs and natural cosmetics. It also includes the preparation, promotion, creation, edition, dissemination, and distribution of all kinds of magazines, books and brochures. The company was founded by Felix Revuelta Fernandez in 1986 and is headquartered in Madrid, Spain.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of 0R9G is 2.48 EUR — it hasn't changed in the past 24 hours. Watch Naturhouse Health SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange Naturhouse Health SA stocks are traded under the ticker 0R9G.
0R9G stock has risen by 0.41% compared to the previous week, the month change is a −3.16% fall, over the last year Naturhouse Health SA has showed a 24.31% increase.
0R9G reached its all-time high on Jan 24, 2018 with the price of 4.46 EUR, and its all-time low was 1.50 EUR and was reached on Oct 3, 2022. View more price dynamics on 0R9G chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0R9G stock is 2.47% volatile and has beta coefficient of 0.30. Track Naturhouse Health SA stock price on the chart and check out the list of the most volatile stocks — is Naturhouse Health SA there?
Today Naturhouse Health SA has the market capitalization of 146.88 M, it has increased by 1.23% over the last week.
Yes, you can track Naturhouse Health SA financials in yearly and quarterly reports right on TradingView.
0R9G net income for the last half-year is 3.90 M EUR, while the previous report showed 6.19 M EUR of net income which accounts for 0.00% change. Track more Naturhouse Health SA financial stats to get the full picture.
Yes, 0R9G dividends are paid quarterly. The last dividend per share was 0.04 EUR. As of today, Dividend Yield (TTM)% is 11.57%. Tracking Naturhouse Health SA dividends might help you take more informed decisions.
Naturhouse Health SA dividend yield was 12.89% in 2025, and payout ratio reached 168.35%. The year before the numbers were 4.89% and 49.24% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 22, 2026, the company has 163 employees. See our rating of the largest employees — is Naturhouse Health SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Naturhouse Health SA EBITDA is 14.45 M EUR, and current EBITDA margin is 30.33%. See more stats in Naturhouse Health SA financial statements.
Like other stocks, 0R9G shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Naturhouse Health SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Naturhouse Health SA technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Naturhouse Health SA stock shows the buy signal. See more of Naturhouse Health SA technicals for a more comprehensive analysis.